Abstract
PHARMACOTHERAPY OF COMORBID CONDITIONS IN PATIENTS ON HEMODIALYSIS.

Anwar Habib and Razi Ahmad*

ABSTRACT

Chronic kidney disease (CKD) is one of the major causes of morbidity and mortality among noncommunicable diseases in India. Majority of the patient chronic kidney disease (CKD) also suffers from 2 to 4 comorbid conditions, hypertension, diabetes mellitus and coronary artery disease tops the list of these comorbid conditions and need an average of 6-8 medications that predispose these patients to medication related problem in the form of both therapeutic failure and drug toxicity mostly because of the ignorance of the prescribing physician about the pharmacokinetic and pharmacodynamic changes that occurs in the various stages of chronic kidney disease that needs drug dose and frequency adjustment especially in the patients of end stage renal disease, the general guidelines provided by different agencies for dose adjustment cannot be applied for all the patients because the pharmacokinetic and pharmacodynamic changes in all the patients are not same it depends on a large number of factors like age, sex, duration and severity of CKD and frequency and dose of hemodialysis received by these patients and also the fluid accumulation in between the subsequent hemodialysis etc. So individual dose adjustment depending on pharmacokinetic and pharmacodynamic changes in a patient will improve the quality and productivity of these patient.

Keywords: CKD, Pharmacotherapy, hemodialysis.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tanima Debnath Sarkar

Download Article : Click here

News & Updation

  • EJBPS: OCTOBER ISSUE PUBLISHED

    OCTOBER 2021 Issue has been successfully launched on 1 October 2021

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT